Cargando…
Disease monitoring of biologic treatment in IBD: early impact and future implications of COVID-19 pandemic
COVID-19 has dominated life in 2020 with, at the time of writing, over 4.9M global cases and >320 000 deaths. The impact has been most intensely felt in acute and critical care environments. However, with most UK elective work postponed, laboratory testing of faecal calprotectin halted due to pot...
Autores principales: | Shields, Stephanie, Dunlop, Allan, Seenan, John Paul, Macdonald, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231430/ https://www.ncbi.nlm.nih.gov/pubmed/34249322 http://dx.doi.org/10.1136/flgastro-2020-101563 |
Ejemplares similares
-
A practical guide to thiopurine prescribing and monitoring in IBD
por: Warner, Ben, et al.
Publicado: (2018) -
An urgent need to institute COVID-19 testing in patients with IBD experiencing flares
por: Quraishi, Mohammed Nabil, et al.
Publicado: (2020) -
Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
por: Dhaliwal, A, et al.
Publicado: (2015) -
Impact of therapeutic drug level monitoring on outcomes of patients with Crohn’s disease treated with Infliximab: real world data from a retrospective single centre cohort study
por: Kamperidis, Nikolaos, et al.
Publicado: (2019) -
Value of drug level testing and antibody assays in optimising biological therapy
por: Vermeire, Séverine, et al.
Publicado: (2013)